Therapeutic effects of human amniotic epithelial cell transplantation on double-transgenic mice co-expressing APPswe and PS1ΔE9-deleted genes

Science China Life Sciences

Volumn 55, Issue 2, 2012, Pages 132-140

  Xue, Shou Ru ^a   Chen, Chong Fang ^a   Dong, Wan Li ^a   Hui, Guo Zhen ^a   Liu, Tian Jun ^b   Guo, Li He ^b  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Alzheimer's disease; human amniotic epithelial cells; spatial memory deficit; transgenic mice

Indexed keywords

ACETYLCHOLINE; AMYLOID PRECURSOR PROTEIN; HOMEODOMAIN PROTEIN; NANOG PROTEIN, HUMAN; OCTAMER TRANSCRIPTION FACTOR 4; PRESENILIN 1;

ALZHEIMER DISEASE; AMNION; ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CELL TRANSPLANTATION; CHOLINERGIC NERVE CELL; CYTOLOGY; DISEASE MODEL; EPITHELIUM CELL; FEMALE; GENE DELETION; GENETICS; GRAFT SURVIVAL; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; METABOLISM; METHODOLOGY; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; TRANSGENIC MOUSE; TRANSPLANTATION; XENOGRAFT;

ACETYLCHOLINE; ALZHEIMER DISEASE; AMNION; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL TRANSPLANTATION; CELLS, CULTURED; CHOLINERGIC NEURONS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; GENE DELETION; GRAFT SURVIVAL; HIPPOCAMPUS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OCTAMER TRANSCRIPTION FACTOR-3; PRESENILIN-1; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

MUS; MUS MUSCULUS;

EID: 84863266757     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-012-4283-1     Document Type: Article

References (30)

1. Breteler M M. Mapping out biomarkers for Alzheimer's disease. JAMA, 2011, 305: 304-305.
2. Bartus R T, Dean III R L, Beer B, et al. The cholinergic hypothesis of geriatric memory dysfunction. Science, 1982, 217: 408-417.
3. Selkoe D J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci 2000, 924: 17-25.
4. Savonenko A, Xu G M, Melnikova T, et al. Episodic-like memory deficits in the APPswe/PS1 dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis, 2005, 18: 602-617.
5. German D C, Yazdani U, Speciale S G, et al. Cholinergic neuropathology in a mouse model of Alzheimer's disease. J Comp Neurol, 2003, 462: 371-381.
6. Ibach B, Haen E. Acetylcholinesterase inhibition in Alzheimer's disease. Curr Pharm Des, 2004, 10: 231-251.
7. Schifilliti D, Santamaria L B, Rosa G, et al. Cholinergic central system, Alzheimer's disease, and anesthetics liaison: a vicious circle? J Alzheimers Dis, 2010, 22: 35-41.
8. Marlatt M W, Lucassen P J. Neurogenesis and Alzheimer's disease: Biology and pathophysiology in mice and men. Curr Alzheimer Res, 2010, 7: 113-125.
9. Adinolfi M, Akle C A, McColl I, et al. Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells. Nature, 1982, 295: 325-327.
10. Uchida S, Inanaga Y, Kobayashi M, et al. Neurotrophie function of conditioned medium from human amniotic epithelial cells. Neurosci Res, 2000, 62: 585-590.
11. Tamagawa T, Oi S, Ishiwata I, et al. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum Cell, 2007, 20: 77-84.
12. Enosawa S, Sakuragawa N, Suzuki S. Possible use of amniotic cells for regenerative medicine. Nippon Rinsho, 2003, 61: 396-400.
13. Sakuragawa N, Thangavel R, Mizuguchi M, et al. Expression of markers for both neuronal and glial cells in human amniotic epithelial cells. Neurosci Lett, 1996, 209: 9-12.
14. Xue S R, Li Q, Khalil Z. Alterations in vascular reactivity in single-and double-transgenic mice coexpressing human APP-C100 and mutant SOD1 genes. Chin Med J (Engl), 2002, 115: 696-701.
15. Yang X X, Xue S R, Dong W L, et al. Therapeutic effect of human amniotic epithelial cell transplantation into the lateral ventricle of hemiparkinsonian rats. Chin Med J (Engl), 2009, 122: 2449-2254.
16. Liu T, Wu J, Huang Q, et al. Human amniotic epithelial cells ameliorate behavioral dysfunction and reduce infarct size in the rat middle cerebral artery occlusion model. Shock, 2008, 29: 603-611.
17. Barinaga M. Fetal neuron grafts pave the way for stem cell therapies. Science, 2000, 287: 1421-1422.
18. Le Belle J E, Svendsen C N. Stem cells for neurodegenerative disorders: where we can go from here? BioDrugs, 2002, 16: 389-401.
19. Cho M S, Hwang D Y, Kim D W. Efficient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale. Nat Protoc, 2008, 3: 1888-1894.
20. Bilic G, Zeisberger S M, Mallik A S, et al. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant, 2008, 17: 955-968.
21. Uchida S, Suzuki Y, Araie M, et al. Factors secreted by human amniotic epithelial cells promote the survival of rat retinal ganglion cells. Neurosci Lett, 2003, 341: 1-4.
22. Arnhold S, Post C, Glüer S, et al. Neuronal characteristics of amniotic fluid derived cells after adenoviral transformation. Cell Biol Int, 2008, 32: 1559-1566.
23. Nilbratt M, Porras O, Marutle A, et al. Neurotrophic factors promote cholinergic differentiation in human embryonic stem cell-derived neurons. J Cell Mol Med, 2010, 14: 1476-1484.
24. Straten G, Eschweiler G W, Maetzler W, et al. Glial cell-line derived neurotrophic factor (GDNF) concentrations in cerebrospinal fluid and serum of patients with early Alzheimer's disease and normal controls. J Alzheimers Dis, 2009, 18: 331-337.
25. Miki T, Lehmann T, Cai H, et al. Stem cell characteristics of amniotic epithelial cells. Stem Cells, 2005, 23: 1549-1559.
26. Kakishita K, Elwan M A, Nakao N, et al. Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: a potential source of donor for transplantation therapy. Exp Neurol, 2000, 165: 27-34.
27. Hagan J J, Salamone J D, Simpson J. Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis. Brain Res, 1988, 27: 9-16.
28. Winkler J, Thal L J, Gage F H, et al. Cholinergic strategies for Alzheimer's disease. J Mol Med, 1998, 76: 555-567.
29. Machova E, Rudajev V, Smyckova H, et al. Function cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1 dE9 transgenic mice. Neurobiol Dis, 2010, 38: 27-35.
30. Reisere R S, Harrison E E, Syverud D C, et al. Impaired spatial learning in the APPswe+PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. Genes Brain Behav, 2007, 6: 54-65.